Success Story: Proving Systemic Benefit Despite a Modest Citation Baseline: EB-2 NIW Success for a Computational Biology Postdoctoral Scholar
Client’s Testimonial:
"I would also like to thank K. R. for her help and support. She has done an amazing job!”
On June 1st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Computational Biology (Approval Notice).
General Field: Computational Biology
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: South Korea
Approval Notice Date: June 1st, 2026
Processing Time: 3 months, 13 days (Premium Processing Requested)
Case Summary:
Our legal team meticulously structured the petition to demonstrate that the client's algorithmic deliverables operate at a level of clear national importance. By building advanced computational frameworks to isolate target biological mechanisms and construct multi-dimensional models of diseased tissue, her research directly furthers mandatory benchmarks outlined under major federal health initiatives. The response successfully argued that her technical deliverables actively advance high-priority federal Research and Development mandates, which direct agencies to fast-track artificial intelligence and biotechnology innovations with wide societal impacts.
Documenting Immediate Independent Implementation
To establish that the client was uniquely well-positioned to advance her proposed work under Matter of Dhanasar, our firm documented an outstanding trajectory of field-wide reliance and peer acclaim:
- Scholarly Outlets: She has published 3 peer-reviewed journal articles and 3 conference abstracts in elite, highly selective venues
- Citation Percentiles: Despite being in the early stages of her postdoctoral career with 8 citations. Normalized metrics verified that her research placed in the top 10% and top 20% of all global papers published in the Molecular Biology & Genetics category for its tracking year.
- Downstream Field-Wide Adoption: The petition showcased verified evidence of independent implementation. Prominent domestic research teams at major institutions have actively integrated her advanced genomic sequencing protocols to resolve complex data-mapping bottlenecks, identify highly repetitive disease-relevant sequences, and trace genetic dysregulation across explicit neurodegenerative and oncogenic pathways.
- Highest Academic Degree: She holds a Ph.D. in Cancer Genomics
- Professional Authority: Her standing was further validated by an exclusive invitation to serve as an expert reviewer at least 1 time.
The Outcome
We effectively argued that forcing this expert through a standard localized labor market test would impose rigid barriers, severely impeding federal efforts to achieve breakthrough health discoveries. This strategic presentation convinced USCIS to grant her I-140 approval on June 1st, 2026, reinforcing the nation's leadership in precision medicine infrastructure.

